Vivotif

Vivotif is a live, attenuated oral vaccine for typhoid fever prevention. This Salmonella Typhi vaccine is administered in capsule form for adults and children. It provides immunity against typhoid infection caused by the Ty21a strain. Suitable for travelers and high-risk populations.

Vivotif is used to help prevent typhoid fever caused by Salmonella Typhi bacteria. It is commonly recommended for travelers to areas where typhoid is common, as well as for household contacts of typhoid carriers. The vaccine works by stimulating the immune system to produce antibodies against the bacteria. It does not treat existing infections.

After taking Vivotif, some people may experience mild stomach upset or nausea. These effects are usually temporary and resolve on their own. The vaccine is designed to be well-tolerated, though individual responses may vary. Most users do not experience significant side effects.

Vivotif should be stored in a cool, dry place away from direct sunlight. It is important to follow the prescribed dosing schedule for full effectiveness. People with weakened immune systems or acute febrile illness should consult a healthcare provider before use. Always inform your doctor about any ongoing medications or conditions.

Vivotif may interact with antibiotics or other medications that weaken the immune system. Avoid taking Vivotif if you are currently on antibiotics, as they may reduce its effectiveness. Alcohol and certain foods do not typically interfere with the vaccine, but follow medical advice for optimal results. Always disclose all medications to your healthcare provider.